IGC Pharma, Inc. (IGC)
0.3077
0.00 (0.00%)
USD |
NYAM |
Aug 26, 16:00
0.3063
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Total Assets (Quarterly) : 9.496M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.496M |
| March 31, 2026 | 9.185M |
| December 31, 2025 | 9.712M |
| September 30, 2025 | 9.743M |
| June 30, 2025 | 7.943M |
| March 31, 2025 | 8.747M |
| December 31, 2024 | |
| September 30, 2024 | 10.37M |
| June 30, 2024 | 10.59M |
| March 31, 2024 | 9.902M |
| December 31, 2023 | 11.26M |
| September 30, 2023 | 16.51M |
| June 30, 2023 | 15.67M |
| March 31, 2023 | 17.18M |
| December 31, 2022 | 20.07M |
| September 30, 2022 | 21.96M |
| June 30, 2022 | 24.17M |
| March 31, 2022 | 26.83M |
| December 31, 2021 | 31.29M |
| September 30, 2021 | 33.84M |
| June 30, 2021 | 34.44M |
| March 31, 2021 | 35.87M |
| December 31, 2020 | 24.16M |
| September 30, 2020 | 26.35M |
| June 30, 2020 | 28.30M |
| Date | Value |
|---|---|
| March 31, 2020 | 28.98M |
| December 31, 2019 | 31.10M |
| September 30, 2019 | 32.89M |
| June 30, 2019 | 33.50M |
| March 31, 2019 | 34.46M |
| December 31, 2018 | 37.16M |
| September 30, 2018 | 16.55M |
| June 30, 2018 | 11.52M |
| March 31, 2018 | 10.85M |
| December 31, 2017 | 11.34M |
| September 30, 2017 | 9.992M |
| June 30, 2017 | 9.436M |
| March 31, 2017 | 11.28M |
| December 31, 2016 | 11.17M |
| September 30, 2016 | 18.86M |
| June 30, 2016 | 18.50M |
| March 31, 2016 | 18.86M |
| December 31, 2015 | 18.40M |
| September 30, 2015 | 18.82M |
| June 30, 2015 | 20.58M |
| March 31, 2015 | 20.33M |
| December 31, 2014 | 21.26M |
| September 30, 2014 | 21.19M |
| June 30, 2014 | 21.61M |
| March 31, 2014 | 17.73M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 675.10M |
| Fulcrum Therapeutics, Inc. | 323.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.364M |
| Shareholders Equity (Quarterly) | 6.132M |
| Debt to Equity Ratio | 0.1765 |
| Current Ratio | 0.3932 |
| Net Debt Paydown Yield | -0.60% |